Lupus and injectables: assessment in facial harmonization

A patient with lupus who seeks harmonization usually already lives with changes in skin, hair, weight and body image, many of them related to the disease and its treatment. This is a patient who deserves a warm welcome, not an automatic refusal. But it is also a patient in whom the underlying condition and the medications change the risk of the procedure, which is why the assessment in facial harmonization needs to be more structured than usual.

This page is for review and planning. It does not replace the assessment of the physician who follows the patient, nor does it define clinical management. Every decision belongs to the qualified professional, according to the rules of their professional council and the product label. The general topic is covered in autoimmune diseases and dermal fillers.

Why does lupus call for caution?

Lupus erythematosus is an autoimmune disease in which the immune system attacks the body's own tissues, with variable involvement of the skin, joints, kidneys and other organs. Some aspects matter directly for facial harmonization:

• Active and remission phases. The risk of reacting to an inflammatory stimulus is higher in the active phase.
• Photosensitivity. Exposure to light can trigger or worsen lesions and systemic symptoms.
• Skin lesions. Some forms of the disease leave the facial skin with lesions, scars or pigment changes.
• Immunosuppressant, antimalarial and corticosteroid medications. They alter healing and infection risk.
• Risk of local inflammatory events. Any procedure that causes inflammation could, in theory, interact with disease activity.

This is not about stating that "lupus rules out facial harmonization." It is about understanding that the patient has a different risk profile and that the decision should be shared.

What should you ask in the medical history?

An objective medical history avoids surprises. Beyond the basic outline in medical history in facial harmonization, investigate:

1. Exact diagnosis and who follows it: rheumatologist, dermatologist or other physician, with contact details.
2. Current phase: recent flare? Last appointment? Disease activity tests up to date?
3. Medications in use: corticosteroids (dose and duration), immunosuppressants, antimalarials, anticoagulants, anti-inflammatories.
4. Lesions on the face: presence, location and history of discoid lesions or scars.
5. Skin behavior: previous reactions to cosmetics, procedures and injections.
6. Sun protection: how the patient protects themselves today and which restrictions their physician has given.
7. Expectation: what they want to change and whether the concern arose from changes caused by the disease or the treatment.
8. Other procedures: laser, peels, microneedling or previous injectables, with any reactions.

How does the disease activity phase change the decision?

The phase of the disease is the axis of the decision. The table summarizes the general reasoning, which should always be validated with the treating physician.

In every row, the patient should be told to seek care if signs of disease activity appear after the procedure, and the treating physician should know what was done.

Does the type of procedure make a difference?

The order of caution usually rises with the inflammatory potential of the procedure, although this is not a fixed rule.

Botulinum toxin

It acts at the neuromuscular junction and is not, by itself, an inflammatory stimulus. The point of attention is the patient's skin and medication. The decision follows the product label and the professional's assessment. See botulinum toxin: fundamentals.

Hyaluronic acid

It is a temporary material, but it triggers a local response and carries a risk of late reaction, nodules or granuloma. In autoimmune diseases, the review literature recommends individualization and caution. The safety approach, including having hyaluronidase available, follows the same logic as any filler. The overview is in safety and complications.

Biostimulators

Because they seek a controlled inflammatory response to stimulate collagen, they deserve even more caution in people with autoimmune disease. See biostimulators: overview and nodules after a biostimulator. If indicated, the decision should be shared, documented and monitored.

Procedures that injure the skin

Laser, peels, microneedling and other technologies that cause inflammation and expose the skin can interact with photosensitivity and healing. See fractional laser and facial harmonization as a reference for staged planning.

How do you document it?

Documentation protects both the patient and the professional. In the patient record, note the reported diagnosis, the phase, the medications, the conversation with the treating physician and the clearance, when there is one. In the informed consent, include a sentence explaining that the underlying disease may increase the risk of reactions and that the patient was told to report any sign of disease activity. The page patient record and documentation in facial harmonization provides the structure.

What can and cannot Harmy do here?

Harmy helps with the conversation about volume, but it does not assess health or replace medical clearance. It detects the face on the device, shows marking points and generates an illustrative simulation of the volume in the chosen areas. It does not detect lesions, disease activity or skin conditions.

If the patient feels more comfortable seeing a gentle simulation before deciding, use Subtle intensity and small volumes, making clear that the clinical decision depends on the physician's clearance. The general flow is in how to use Harmy.

Review quiz

When to decline or postpone

There are legitimate reasons to decline or postpone: active disease, a skin lesion in the area, recent use of a high corticosteroid dose, infection, no clearance when you consider it necessary, or an expectation the procedure cannot meet. Recording the decision and offering a new assessment at a more stable time is part of the care.

In short: a patient with lupus may, in certain scenarios, be a candidate for facial harmonization procedures, but the path goes through a joint assessment, careful documentation, smaller stages and vigilance. Respecting that pace is what turns a risky situation into a defensible approach.